Press Release

Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.

Gelclair® is the company's third commercialized prescription product

Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force

Severe mucositis/pharyngitis occurred in 70% of head and neck cancer patients in third-party study

Read More